Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natoli

Showing results (1081-1090 of 1,181) with videos related to

Pageof 119
Sort By:
Surgical Oncology|February 18, 2026
Clinical protocol for the K-3 trial: a single-center, patient-blinded, randomized clinical trial addressing anesthesiologic, oncological and patient recovery outcomes of standard flank approach vs supine approach for robot-assisted partial nephrectomyStefano Tappero, Sofia Giudici, Elio Mazzone, et al.
Metabolism: Clinical and Experimental|May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trialAndrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Blood|January 1, 2005
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesRobert Z Orlowski, Peter M Voorhees, Reynaldo A Garcia, et al.
Clinical and Experimental Rheumatology|December 26, 2023
Clinical features, treatment and outcomes of Italian children with enthesitis-related arthritis and juvenile psoriatic arthritis: a cross-sectional cohort studyAna Isabel Rebollo-Giménez, Silvia Rosina, Valentina Natoli, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Journal of Cellular Physiology|November 19, 2016
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast CancerTeresa Gamucci, Lucia Mentuccia, Clara Natoli, et al.
Thescientificworldjournal|June 25, 2020
Mesotherapy: From Historical Notes to Scientific Evidence and Future ProspectsMassimo Mammucari, Enrica Maggiori, Domenico Russo, et al.
Immunity|July 19, 2014
Macrophage activation and polarization: nomenclature and experimental guidelinesPeter J Murray, Judith E Allen, Subhra K Biswas, et al.
Cancer Discovery|May 6, 2016
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesEejung Kim, Nina Ilic, Yashaswi Shrestha, et al.
Pageof 119

Showing results (1081-1090 of 1,181) with videos related to

Sort By:
Pageof 119
Surgical Oncology|February 18, 2026
Clinical protocol for the K-3 trial: a single-center, patient-blinded, randomized clinical trial addressing anesthesiologic, oncological and patient recovery outcomes of standard flank approach vs supine approach for robot-assisted partial nephrectomyStefano Tappero, Sofia Giudici, Elio Mazzone, et al.
Metabolism: Clinical and Experimental|May 14, 2016
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trialAndrew L Siebel, Si Khiang Trinh, Melissa F Formosa, et al.
Blood|January 1, 2005
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesRobert Z Orlowski, Peter M Voorhees, Reynaldo A Garcia, et al.
Clinical and Experimental Rheumatology|December 26, 2023
Clinical features, treatment and outcomes of Italian children with enthesitis-related arthritis and juvenile psoriatic arthritis: a cross-sectional cohort studyAna Isabel Rebollo-Giménez, Silvia Rosina, Valentina Natoli, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Journal of Cellular Physiology|November 19, 2016
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast CancerTeresa Gamucci, Lucia Mentuccia, Clara Natoli, et al.
Thescientificworldjournal|June 25, 2020
Mesotherapy: From Historical Notes to Scientific Evidence and Future ProspectsMassimo Mammucari, Enrica Maggiori, Domenico Russo, et al.
Immunity|July 19, 2014
Macrophage activation and polarization: nomenclature and experimental guidelinesPeter J Murray, Judith E Allen, Subhra K Biswas, et al.
Cancer Discovery|May 6, 2016
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesEejung Kim, Nina Ilic, Yashaswi Shrestha, et al.
Pageof 119